Nanotechnology : San Diego

Drug Delivery 2007: Where Science and Business Meet

Benj — Tue, 05 Dec 2006 12:49:44 +0000

Short description

This must-attend conference for the drug delivery community brings together expert speakers from the Drug Delivery, Pharmaceutical, Biotechnology, Device and Venture Capital fields. Unlike other drug delivery conferences, we offer six distinct scientific tracks covering the latest discoveries and trends in nanotechnology, transdermal, ophthalmic, oral, injectables and nasal/pulmonary delivery, while our business and science track provides practical, actionable information about the latest issues relevant to the entire drug delivery community. New this year are our extensive regulatory and compliance sessions. You’ll also find all-new topics such as prodrugs and gene therapy.

Long description

>> The latest advances in drug delivery in the following fields:
o nanotechnology
o transdermal
o ophthalmic
o oral
o injectables
o nasal/pulmonary
>> The challenges and opportunities facing the drug delivery community as a whole
>> The most promising novel delivery systems for macromolecules, proteins, peptides and nanoparticles
>> Why particle engineering and biomaterials are key to the advancement of drug delivery
>> What drug delivery systems are currently in development
>> The latest Industry partnering trends
>> How to transition from a drug delivery company to a pharmaceutical company
>> How to attract venture capital

…and more!

Event precise location and contact information

Interested in being part of our world-class speaking faculty at Drug Delivery 2007?

Contact Wen Minkoff at wminkoff@frallc.com or (831) 465-2284 to submit your proposal!

Web site Url link

http://www.pharmedassociates.com/

Web site Url text

Pharmedassociates

Nanogen, Inc.

Benj — Fri, 25 Aug 2006 18:19:02 +0000

Ticker Id

Web url

http://www.nanogen.com/

Contact Email

Short description

Street address

10398 Pacific Center Court

Zip or postal code

92121

Telephone

877-626-6436

Fax

858-410-4952

Foundation date

Ceo, president

Howard Birndorf

Number of employees

Long description

Nanogen's mission is to become a leading supplier of molecular diagnostic tests to the medical community and to clinical researchers. We commercialize instruments, consumables, electronic microarrays and reagents through a direct sales force and distributors in North America, Europe and Asia. We also provide a highly experienced technical support staff and Field Application Specialists dedicated to helping our customers around the world.

The NanoChip Molecular Biology Workstation, our first commercial product, is an automated, multi-purpose instrument primarily used for DNA-based analyses. Researchers in the field of molecular biology and genetics use the platform to study how genes function and to understand the correlation between genetic variation and disease. The NanoChip System can also be used for human identification, important in the forensics field.

Our system is uniquely bridging the gap between early-stage scientific research and actual clinical practice, delivering certainty, control and consolidation.

Additional Commentaries and remarks

Patents

SAIC

Benj — Tue, 17 Oct 2006 13:14:01 +0000

Ticker Id

Web url

http://www.saic.com/

Contact Email

Short description

Street address

10260 Campus Point Drive

Zip or postal code

92121

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

We are a leading provider of scientific, engineering, systems integration and technical services and products to all branches of the U.S. military, agencies of the U.S. Department of Defense (DoD), the intelligence community, the U.S. Department of Homeland Security (DHS) and other U.S. Government civil agencies, as well as to customers in selected commercial markets. Our customers seek our domain expertise to solve complex technical challenges requiring innovative solutions for mission-critical functions in such areas as national security, intelligence and homeland defense. Increasing demand for our services and products is driven by priorities including the ongoing global war on terror and the transformation of the U.S. military.

Additional Commentaries and remarks

Patents

Stemedica Cell Technologies, Inc.

Benj — Sat, 09 Jun 2007 11:39:29 +0000

Ticker Id

Web url

http://www.stemedica.com/about/default.asp

Contact Email

Short description

Street address

5375 Mira Sorrento Pl, Suite 100

Zip or postal code

92121

Telephone

858-658-0910

Fax

858-658-0986

Foundation date

Ceo, president

Number of employees

Long description

These accomplishments are driven by a world class team of prominent scientists, leading clinicians, and executives from successful nutritional, medical and pharmaceutical businesses. The members of the team are located in Centers of Excellence in San Diego, CA, Palo Alto, CA, and Eastern Europe and are directed toward solving the problems associated with this new generation of medicine.

Stemedica Cell Technologies is supported by both individual and institutional funding. Our experienced management team has been responsible for launching several successful companies and the members of our Founders and Scientific Advisory Board have been involved in developing and bringing to market "industry first" medical device, biotech, pharmaceutical and nutraceutical products. We are committed to, and capable of, delivering sustained growth and superior value to our shareholders.

Stemedica is becoming one of the undisputed leaders in engineering the new frontier of adult stem cell methodologies, technologies, therapies and treatment protocols.

Additional Commentaries and remarks

Patents

Accelrys, Inc.

Benj — Sat, 26 Aug 2006 15:27:48 +0000

Ticker Id

Web url

http://www.accelrys.com/

Contact Email

Short description

Street address

10188 Telesis Court, Suite 100

Zip or postal code

92121

Telephone

+1 858 799 5000

Fax

+1 858 799 5100

Foundation date

Ceo, president

Number of employees

Long description

Accelrys, Inc.(NASDAQ: ACCL), formerly Pharmacopeia, Inc., incorporated in 1993, develops and commercializes scientific software and technology that accelerates and improves drug discovery and chemical development. The Company's molecular modeling, simulation, informatics, workflow and data pipelining software supports both the life sciences and materials research markets. Its life science solutions support pharmaceutical biotechnology companies, while its material science solutions support companies that develop companies that develop and optimize materials and chemicals, such as companies serving the chemicals, petrochemicals, food, personal care products, electronics and nanotechnology industries.

Accelrys' software covers a range of disciplines, including gene sequence analysis, proteomics, rational drug design, lead optimization, materials research and formulation design. These software products help researchers increase the speed and efficiency of the research and development cycle. Accelrys' software customers include government and academic institutions, as well as commercial organizations within the pharmaceutical, biotechnology, chemical, petroleum and semiconductor sectors. Accelrys has active license agreements with a number of chemical, biotechnology and pharmaceutical organizations.

Accelrys' Modeling and Simulation software product suite is comprised of quantum mechanical simulation, molecular simulation and mesoscale simulation technologies. This product suite consists of over 100 application modules based on its own technologies that merge fundamental scientific principles with advanced computer visualization, molecular modeling and computational chemistry techniques. These products, which are principally used by specialist computational chemists and biologists, allow scientists to compute chemical, biological and materials properties, to simulate, visualize and analyze chemical and biological systems and to communicate the results to other scientists. These products have been designed within flexible software architectures that facilitate the development, integration and deployment of new products. It also offers open access to many of its core software development environments.

The Company's line of Informatics Software is comprised of bioinformatics and cheminformatics solutions. Its bioinformatics solutions include a suite of programs enabling molecular biologists to search, edit, compare, map and align sequence data. Researchers use these products to enable the analysis of deoxyribonucleic acid (DNA) and protein sequences and structure, predict ribonucleic acid (RNA) secondary structure and annotate protein sequences. The Company also provides enterprise-wide tools that assist in the management and analysis of this data. Accelrys' cheminformatics software includes data visualization and analysis software to search, retrieve and use chemical structures, biological and chemical data, experimental data and registration information. Most of these tools use industry standard software components and are compliant with commonplace applications, such as Microsoft Excel. Accelrys also uses this cheminformatics component technology and database architectures to build customized enterprise-wide systems for client companies, and also sells these implemented components to customers who want to build or customize their own systems.

Additional Commentaries and remarks

Patents

GeneOhm Sciences, Inc. ( Acquired by BD )

Benj — Fri, 18 Aug 2006 15:37:48 +0000

Ticker Id

Web url

http://www.geneohm.com/

Contact Email

Short description

Street address

6146 Nancy Ridge Drive

Zip or postal code

92121

Telephone

(858) 334-6300

Fax

(858) 334-6301

Foundation date

Ceo, president

Number of employees

Long description

Established in San Diego, California in 2001, GeneOhm Sciences has assembled an exceptional team including experienced management, talented scientists, top-tier investors and an outstanding Board of Directors. Together we are creating a proprietary platform and portfolio of applications that will allow clinicians to rapidly and inexpensively identify mutations in a patient's genome or detect nucleic acid micro-organisms that cause infectious disease. Our multiplex platform will enable clinicians to apply molecular diagnostics to individual patient care.

Additional Commentaries and remarks

Patents

NanoScience + Engineering 2008 - Part of SPIE Optics + Photonics

Sat, 15 Sep 2007 22:58:49 +0000

Short description

Long description

Plan to attend NanoScience + Engineering, one of the largest and most important technical conferences covering developing technologies at the nanoscale, current and future applications, and the environmental, health, and safety issues that must be addressed.
Hear over 500 technical presentations, learn the latest from noted plenary speakers; attend specially designed courses for those working in the field; visit exhibiting companies that are taking the science of nanotechnology to applications. NanoScience + Engineering will provide the networking opportunities you need to stay current and the information you need to advance understanding of the field. Don't miss the Symposium-wide and NanoScience + Engineering Plenary Events.

Event precise location and contact information

San Diego Convention Center

Web site Url link

http://spie.org/nanoscience-engineering.xml?WT.mc_id=RCALENDARW

Web site Url text

http://spie.org/nanoscience-engineering.xml?WT.mc_id=RCALENDARW

nanoComposix, Inc.

Benj — Wed, 16 Aug 2006 14:12:41 +0000

Ticker Id

Web url

http://www.nanocomposix.com/

Contact Email

Short description

Street address

4878 Ronson Court

Zip or postal code

92111

Telephone

619.890.0704

Fax

619.330.2556

Foundation date

Ceo, president

Number of employees

Long description

Using methods of templating, electroless metal deposition, layer-by-layer assembly, and other nanofabrication techniques, we fabricate nanocomposite materials with specific sizes, shapes, densities, porosities, surface charges, and surface chemistries. The sequential method of fabrication allows us to produce custom multifunctional nanocomposite materials that are specifically tailored for our customer's applications.

Additional Commentaries and remarks

Patents

Apex Nanomaterials

Benj — Fri, 09 Mar 2007 11:06:28 +0000

Ticker Id

Web url

http://www.apexnanomaterials.com/

Contact Email

Short description

Street address

7945 Silverton, Suite 1101

Zip or postal code

92126

Telephone

(877) 576-6038

Fax

(858) 847-9608

Foundation date

Ceo, president

sales@apexnanomaterials.com

Number of employees

Long description

Our leading expertise in SWNTs purification, processing and functionlization make Apex Nanotmaterials the only one to be able to supply SWNTs and its nanostructured Composite Materials in a wide range of states, including purified SWNTs at different levels (>70%, >90% and >95%) with different methods (chemically and physically), processable SWNTs for both water and organic solvents and different Composite Materials with various Matrix/Substrates which include both inorganic and organic/polymeric materials.

Our products are being used to research and develop a number of revolutionizing products including field emission display (FED), Reinforced Multiple Functional Advanced Composite Materials (RMFACM) and Molecular and Biosesnors. As one of only a few companies today to commercialize SWNTs production and its processable Composite Materials at a industry scale, the Company’s goal is to provide SWNTs materials at an industrial scale yet with the best quality in a most affordable price.

Additional Commentaries and remarks

Patents

Proteinx Lab

Benj — Sat, 19 Aug 2006 15:04:19 +0000

Ticker Id

Web url

http://www.proteinx.com/

Contact Email

Short description

Street address

4178 Sorrento Valley Blvd., Suite i

Zip or postal code

92121

Telephone

858-678-8765

Fax

413-751-0277

Foundation date

Ceo, president

Number of employees

Long description

We supply new proteins to the research community, and perform the finest protein purification and analysis. The trueth is that your proteins will be purified by our hands-on Ph.D. scientists. We also offer biomolecular interaction analysis by using Biacore 1000. One nice thing about our service is that your payment is due only when your proteins are ready to deliver, neither prepayment nor milestone payments will be asked. In the case that we fail to get your proteins, there is no charge. It is a high end R&D service. We may be involved in your project only if you fail to get your protein, but really want it. 5 finest structural biology labs in the nation are teamed up with our lab to provide protein structure determination.

Yes! You come to the promising land, where you may be assisted to get your soft diamonds (proteins). With them, you may explore your wonder world.
And yes! We have a dream of that we will be able to supply self-assemble peptides/proteins for construction of nanodevices from the bottom up.

Additional Commentaries and remarks

Patents

Solulink

Benj — Tue, 29 Aug 2006 21:14:08 +0000

Ticker Id

Web url

http://www.solulink.com/

Contact Email

solulink@solulink.com

Short description

Street address

9853 pacific Heights Blvd., Suite H

Zip or postal code

92121

Telephone

858.625.0670

Fax

858.625.0770

Foundation date

Ceo, president

David Schwartz, Steve DeGraw

Number of employees

Long description

Solulink has developed highly efficient chemistries for precisely linking one biomolecule to another or attaching complex biomolecules to a surface (e.g., a micro array or biochip) with unprecedented control over the structure and function of the resulting product. Solulink’s proprietary bioconjugation technology can dramatically improve the performance of current products and enable entirely new product opportunities in fields ranging from diagnostics and therapeutics to nanotechnology. Solulink’s broadly applicable bioconjugation technology that is the first advance in its field in over a decade and it satisfies an unmet need in the preparation and expanded utility of crucial components in many biomedical areas including applications for in vitro diagnostics, biomedical research and therapeutics. The inherent properties of Solulink’s technology provide the functional and economic advantages that address these problems in these multi-billion dollar markets. Solulink’s bioconjugates will lead to the replacement of current conjugation technologies resulting in improved products and enable the development of new applications in both genomics and proteomics that cannot be satisfied with current methods.

Additional Commentaries and remarks

Patents

Syrrx, Inc. ( Acquired by Takeda Pharmaceutical Company Limited )

Benj — Tue, 22 Aug 2006 12:18:53 +0000

Ticker Id

Web url

http://www.syrrx.com/

Contact Email

Short description

Street address

10410 Science Center Drive

Zip or postal code

92121

Telephone

(858) 622-8528

Fax

(858) 550-0526

Foundation date

Ceo, president

Number of employees

Long description

Syrrx's recently completed research facility is capable of accommodating about 250 researchers, of which will be approximately 50 chemists in support of the continued expansion of its drug discovery efforts. The facility houses the company's structural biology, medicinal chemistry, combinatorial chemistry, and nanotechnology programs as well as advanced supercomputing capabilities and corporate offices.
Imagine a time when new medicines are designed atom by atom. Imagine when we are able to visualize a disease and treat that disease Ч— because we can literally 'see' the problem at the molecular level.

For certain diseases, that time is now. Syrrx is a next generation rational drug discovery company designing potent, highly selective drugs by 'visualizing' precisely how they bind their targets. Detailed knowledge of how drugs bind their targets enables Syrrx scientists to design drugs of exquisite potency and selectivity to address unmet medical needs.

Additional Commentaries and remarks

Patents

Filmetrics Inc.

Benj — Tue, 22 Aug 2006 16:59:43 +0000

Ticker Id

Web url

http://www.filmetrics.com/

Contact Email

info@filmetrics.com

Short description

Street address

9335 Chesapeake Drive

Zip or postal code

92123

Telephone

858-573-9300

Fax

858-573-9400

Foundation date

Ceo, president

Number of employees

Long description

Prior to our arrival, commercial thin-film measurement instruments cost $50,000 or more and required operators to have advanced training. Single measurements took several minutes, even hours.

The Filmetrics approach was to design an affordable purpose-built miniature spectrometer system, whose low-cost had just recently been made possible by advances in silicon detector array technology. We combined this with sophisticated software that integrated advanced thin-film expertise into a simple, intuitive Windows interface. The result was the F20, a compact system with astounding speed and accuracy, and which line operators could be trained to use in a matter of minutes. And all at a mere fraction of the cost of traditional instruments.

Our accomplishments have been widely recognized by the industry press. For example, R&D Magazine judged the Filmetrics F30 as one of the "100 Most Technologically Significant" products of 1997, and Photonics Spectra named the F20 as one of the "25 Best New Products" of 1998. And Filmetrics continues to innovate, again winning the R&D 100 Award in 2002 for the STMapper.

Additional Commentaries and remarks

Patents

RASIRC

Benj — Tue, 22 May 2007 10:46:34 +0000

Ticker Id

Web url

http://www.rasirc.com/

Contact Email

info@rasirc.com

Short description

Street address

11760 Sorrento Valley Road, Suite E

Zip or postal code

92121

Telephone

858.259.1220

Fax

Foundation date

Ceo, president

Number of employees

Long description

Unique and proprietary products have been developed around membrane technology. Attention to materials, sealing technology and whole product requirements has led to the development of products that are safer, lower cost, and out perform any alternative. Custom solutions are of interest to us.

Improving the growth rate and uniformity of carbon nanotubes is a major hurdle to transfer of this technology from research to production. The process of growing carbon on catalyst leads to self poisoning of the catalyst and cession of the process. Through the addition of small amounts of water vapor, the catalyst can be kept free of molecular contamination. This enables longer carbon fiber to be grown under the same general process conditions.

Additional Commentaries and remarks

Patents

Nanotrope, Inc.

Benj — Fri, 01 Sep 2006 13:54:39 +0000

Ticker Id

Web url

http://www.nanotrope.com/

Contact Email

admin@nanotrope.com

Short description

Street address

3030 Bunker Hill St.

Zip or postal code

92109

Telephone

858-270-7992

Fax

Foundation date

Ceo, president

Number of employees

Long description

Nanotrope is an early stage, privately held company developing engineered nanoparticles for drug
delivery and other biomedical applications.

Nanotrope has assembled a world class team from industrial and academic backgrounds, with extensive experience in driving early stage technologies to commercial success.

Additional Commentaries and remarks

Patents

JMAR Technologies, Inc.

Benj — Thu, 24 Aug 2006 15:35:39 +0000

Ticker Id

Web url

http://www.jmar.com/

Contact Email

Short description

Street address

10905 Technology Place

Zip or postal code

92127

Telephone

(858) 946-6800

Fax

(858) 946-6899

Foundation date

Ceo, president

Number of employees

Long description

JMAR is the world's leading developer and manufacturer of collimated laser plasma lithography (CPL) sources and systems and X-ray lithography stepper systems for the semiconductor industry. It also develops proprietary advanced lasers and one nanometer and EUV light sources for other high-value microelectronics applications. In addition, JMAR provides semiconductor process technologies and services and manufactures precision measurement, positioning and light based manufacturing systems for inspection, repair and fabrication of semiconductors, data storage devices, biomedical and optical communications products.

By integrating JMAR's leading-edge collimated laser plasma lithography X-ray sources with the X-ray steppers of JMAR/SAL NanoLithography, Inc. (formerly SAL, Inc. aquired in 2001) (JSAL), JMAR is one of only two remaining U.S.-owned lithography system companies. JMAR's first strategic target is to provide manufacturers of high-speed gallium arsenide semiconductors an integrated CPL processing capability. We believe JMAR will subsequently be able to provide more affordable sub- 0.13-micron silicon chip processing on an earlier timetable than currently projected for alternative next generation lithography ("NGL") technologies, such as EUV. By combining JSAL's technical and professional talent with JMAR's world-class advanced light technology we intend to position JMAR as the world's premier provider of high-performance NGL systems for both the silicon and compound semiconductor industries.

Additional Commentaries and remarks

Patents

Applied Molecular Evolution, Inc.

Benj — Wed, 23 Aug 2006 17:28:17 +0000

Ticker Id

Web url

http://www.amevolution.com/

Contact Email

Short description

Street address

3520 Dunhill Street

Zip or postal code

92121

Telephone

858.597.4990

Fax

858.597.4950

Foundation date

Ceo, president

Number of employees

Long description

AME's research team applies our proprietary AMEsystem directed evolution protein engineering technology to create improved therapeutic protein candidates. The AMEsystem was designed, developed and continuously upgraded over the last decade by our research team specifically to address the unique challenges of optimizing human biotherapeutics. In the process, AME has also developed an unparalleled record of success in optimizing protein therapeutic candidates.

Directed Evolution is a precise and controlled three-step process to create proteins with optimized functions. In the first step, a library of variant genes is created based on an initial gene that encodes for a protein of interest. In the second step, the variant genes are expressed into functional proteins. In the third step, the proteins are screened, or tested, for improved function.

Additional Commentaries and remarks

Patents

Center for Nanosciences and Nanotechnology

aneeshasks — Wed, 27 Feb 2008 19:47:50 +0000

Short description

Center for Nanosciences and Nanotechnology at Universidad Nacional Autonoma de México (UNAM) Ensenada

Thursday, March 13, 2008 @ Fish & Richardson Law Offices 12390 El Camino Real San Diego, CA, 92130 from 5:30 pm - 8:30 pm

The debut of UNAM Ensenada’s Center for Nanoscience and Nanotechnology marks the trend of newly inaugurated departments focused on nanotechnology in universities around the world. UNAM is already recognized as the university with the highest concentration of researchers working on nanotechnology and some of the most ambitious projects. At UNAM Ensenada this announcement ties into an overall vision for the region that includes vinculation, innovation and economic sustainability through industrial applications of breakthrough technology.

Distinguished Speakers:

Dr. Carlos Aramburo de la Hoz
National Scientific Coordinator
UNAM, Mexico City, Mexico

Dr. Sergio Fuentes
Director UNAM Ensenada

Dr. Nina Bogdanchikova
Principal Investigator, UNAM Ensenada

Long description

Event precise location and contact information

Fish & Richardson Law Offices
12390 El Camino Real
San Diego, CA, 92130

Web site Url link

http://www.nanobionexus.org/events.aspx

Web site Url text

NanoBioNexus

Benj — Tue, 29 Aug 2006 13:34:08 +0000

Ticker Id

Web url

http://www.nanobionexus.org/

Contact Email

Short description

Street address

Zip or postal code

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Our vision is to be recognized as the leading group of economic observers and business arbiters for the nanobiotechnology field. The group's target audience is business and legal professionals, venture capitalists, entrepreneurs, academia, and members of the general public with an interest in nanobiotechnology.

Additional Commentaries and remarks

Patents

SPIE Optics + Photonics 2009

Admin — Fri, 19 Sep 2008 12:49:23 +0000

Short description

The conference and exhibition where optical engineering meets emerging technologies of nanotechnology and science, photonic devices and solar energy and their applications.

Long description

The conference and exhibition where optical engineering meets emerging technologies of nanotechnology and science, photonic devices and solar energy and their applications.
Hear the latest research from four international symposia:
• Optical Engineering + Applications
• Nanoscience + Engineering
• Photonic Devices + Applications
• Solar Energy + Applications
With over 3,100 technical presentations, 70 courses, over 5,000 scientists, engineers, managers and instrumentation innovators, and over 280 exhibitors, Optics + Photonics offers you both classic and cutting-edge optics and photonics research, training and product information.
Keep abreast of emerging technologies and market trends in organic photovoltaic energy sources, nanotechnology, solid state lighting, and solar energy. Hear top-level speakers and over 1,000 technical presentations that focus on these exciting new developments.
Get the kind of technical information, professional training, hardware and market intelligence that is key to success in today's changing job and technology landscape.

Event precise location and contact information

San Diego Convention Center
San Diego, California, USA

2-6 August 2009

http://spie.org/optics-photonics.xml?WT.mc_id=RCALENDARW

Web site Url link

http://spie.org/optics-photonics.xml?WT.mc_id=RCALENDARW